Ant sting mortality in Australia.

We investigated ant sting related fatalities in Australia over the period 1980-1999. Data was obtained from the Australian Bureau of Statistics and state coronial authorities. Six ant sting-related fatalities were identified, five in Tasmania and one in New South Wales. All were males aged between 40 and 80-years-of-age and most (5/6) had prior histories of jumper or bull ant (Myrmecia spp.) venom allergy. However, none of the deceased carried injectable adrenaline and most died within 20 min of a single sting. Significant cardiopulmonary co-morbidities were identified in all cases and, in addition, moderate-severe laryngeal oedema and coronary atherosclerosis was observed in most (4/6) cases at autopsy. Where ascertained, Myrmecia ant venom specific immunoglobulin E antibodies levels were always elevated and fell into two distinct patterns of immunoreactivity. Adult Tasmanian males with a prior history of ant venom allergy and cardiopulmonary co-morbidities are therefore at highest risk of a fatal outcome from ant stings. Deaths may be avoided by the early recognition of anaphylaxis and self-treatment with adrenaline as well as by the development of purified Myrmecia ant venom immunotherapy.

[1]  B. Przybilla,et al.  Constitutively raised serum concentrations of mast-cell tryptase and severe anaphylactic reactions to Hymenoptera stings , 2001, The Lancet.

[2]  J. Cleland INSECTS IN THEIR RELATIONSHIP TO INJURY AND DISEASE IN MAN IN AUSTRALIA , 1931 .

[3]  Graham O Solley Allergy to stinging and biting insects in Queensland , 1990, The Medical journal of Australia.

[4]  J. Tunon-de-lara,et al.  ACE inhibitors and anaphylactoid reactions during venom immunotherapy , 1992, The Lancet.

[5]  L. Schwartz,et al.  Time course of appearance and disappearance of human mast cell tryptase in the circulation after anaphylaxis. , 1989, The Journal of clinical investigation.

[6]  S. Sutherland,et al.  Immediate allergic reactions to Myrmecia ant stings: immunochemical analysis of Myrmecia venoms , 1994, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[7]  R. Good,et al.  Successful rush immunotherapy for anaphylaxis to imported fire ants. , 1998, The Journal of allergy and clinical immunology.

[8]  W. Hodgson,et al.  Some enzymic activities of two Australian ant venoms: a jumper ant Myrmecia pilosula and a bulldog ant Myrmecia pyriformis. , 1994, Toxicon : official journal of the International Society on Toxinology.

[9]  S. Sutherland Deaths from snake bite in Australia, 1981–1991 , 1992, The Medical journal of Australia.

[10]  T. Freeman,et al.  Imported fire ant immunotherapy: effectiveness of whole body extracts. , 1992, The Journal of allergy and clinical immunology.

[11]  R. Langley,et al.  Deaths resulting from animal attacks in the United States. , 1997, Wilderness & environmental medicine.

[12]  B. Baldo,et al.  Molecular cloning and characterization of a major allergen (Myr p I) from the venom of the Australian jumper ant, Myrmecia pilosula. , 1993, Biochimica et biophysica acta.

[13]  J. Harrison,et al.  Wasp sting mortality in Australia , 2000, The Medical journal of Australia.

[14]  W. Hodgson,et al.  Pharmacological studies of jumper ant (Myrmecia pilosula) venom: evidence for the presence of histamine, and haemolytic and eicosanoid-releasing factors. , 1992, Toxicon : official journal of the International Society on Toxinology.

[15]  J. H. Barnard Studies of 400 Hymenoptera sting deaths in the United States. , 1973, The Journal of allergy and clinical immunology.

[16]  S. Sutherland Australian animal toxins: The creatures, their toxins, and care of the poisoned patient , 1983 .

[17]  J A Prahlow,et al.  Fatal anaphylaxis due to fire ant stings. , 1998, The American journal of forensic medicine and pathology.

[18]  R. W. Taylor,et al.  Ants of the genus Myrmecia Fabricius: a preliminary review and key to the named species (Hymenoptera: Formicidae: Myrmeciinae) , 1991 .

[19]  R. Rhoades,et al.  Survey of fatal anaphylactic reactions to imported fire ant stings. Report of the Fire Ant Subcommittee of the American Academy of Allergy and Immunology. , 1989, The Journal of allergy and clinical immunology.

[20]  David F. Williams,et al.  Fire Ant Attacks on Residents in Health Care Facilities: A Report of Two Cases , 1999, Annals of Internal Medicine.

[21]  R. Jacobs,et al.  In vivo and in vitro comparison of fire ant venom and fire ant whole body extract. , 1983, The Journal of allergy and clinical immunology.

[22]  J. Nystrand,et al.  A new radioimmunoassay for human mast cell tryptase using monoclonal antibodies. , 1991, Journal of immunological methods.

[23]  C. Stafford,et al.  Hypersensitivity to fire ant venom. , 1996, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[24]  P. Clarke The natural history of sensitivity to jack jumper ants (Hymenoptera formicidae Myrmecia pilosula) in Tasmania. , 1986, The Medical journal of Australia.

[25]  R. Southcott Some harmful Australian insects , 1988, The Medical journal of Australia.

[26]  J. Douglass,et al.  Stinging insect allergy , 1999, The Medical journal of Australia.

[27]  A. Austin,et al.  Hymenoptera: Evolution, Biodiversity and Biological Control , 2000 .

[28]  S. Sutherland,et al.  Snakebite deaths in Australia 1992‐1994 and a management update , 1995, The Medical journal of Australia.

[29]  R. Lockey,et al.  Monograph on insect allergy. , 1981 .

[30]  J. Ring,et al.  The renin angiotensin system and hymenoptera venom anaphylaxis , 1993, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[31]  N. Levick,et al.  European wasps: an emerging hazard in Australia , 1997, The Medical journal of Australia.

[32]  J. Trinca INSECT ALLERGY IN AUSTRALIA: RESULTS OF A FIVE‐YEAR SURVEY 1 , 1964, The Medical journal of Australia.

[33]  B. Baldo,et al.  Molecular cloning and characterization of the major allergen Myr p II from the venom of the jumper ant Myrmecia pilosula: Myr p I and Myr p II share a common protein leader sequence. , 1996, Biochimica et biophysica acta.

[34]  R. Heddle,et al.  Bee‐sting mortality in Australia , 1984, The Medical journal of Australia.